The impact of hypoxia on B cells in COVID-19

BACKGROUND: Prominent early features of COVID-19 include severe, often clinically silent, hypoxia and a pronounced reduction in B cells, the latter important in defence against SARS-CoV-2. This presentation resembles the phenotype of mice with VHL-deficient B cells, in which Hypoxia-Inducible Factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotagiri, Prasanti, Mescia, Federica, Hanson, Aimee L., Turner, Lorinda, Bergamaschi, Laura, Peñalver, Ana, Richoz, Nathan, Moore, Stephen D., Ortmann, Brian M., Dunmore, Benjamin J., Morgan, Michael D., Tuong, Zewen Kelvin, Göttgens, Berthold, Toshner, Mark, Hess, Christoph, Maxwell, Patrick. H., Clatworthy, Menna. R., Nathan, James A., Bradley, John R., Lyons, Paul A., Burrows, Natalie, Smith, Kenneth G.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856886/
https://www.ncbi.nlm.nih.gov/pubmed/35189575
http://dx.doi.org/10.1016/j.ebiom.2022.103878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856886/
https://www.ncbi.nlm.nih.gov/pubmed/35189575
http://dx.doi.org/10.1016/j.ebiom.2022.103878

Ejemplares similares